253 related articles for article (PubMed ID: 20013195)
1. Application of membrane extraction with sorbent interface for breath analysis.
Ma V; Lord H; Morley M; Pawliszyn J
Methods Mol Biol; 2010; 610():451-68. PubMed ID: 20013195
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human breath with micro extraction techniques and continuous monitoring of carbon dioxide concentration.
Ma W; Liu X; Pawliszyn J
Anal Bioanal Chem; 2006 Aug; 385(8):1398-408. PubMed ID: 16847622
[TBL] [Abstract][Full Text] [Related]
3. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
4. Human exhaled air analytics: biomarkers of diseases.
Buszewski B; Kesy M; Ligor T; Amann A
Biomed Chromatogr; 2007 Jun; 21(6):553-66. PubMed ID: 17431933
[TBL] [Abstract][Full Text] [Related]
5. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
6. Sorbent-based sampling methods for volatile and semi-volatile organic compounds in air. Part 2. Sorbent selection and other aspects of optimizing air monitoring methods.
Woolfenden E
J Chromatogr A; 2010 Apr; 1217(16):2685-94. PubMed ID: 20106482
[TBL] [Abstract][Full Text] [Related]
7. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
8. Breath acetone analysis with miniaturized sample preparation device: in-needle preconcentration and subsequent determination by gas chromatography-mass spectroscopy.
Ueta I; Saito Y; Hosoe M; Okamoto M; Ohkita H; Shirai S; Tamura H; Jinno K
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2551-6. PubMed ID: 19595647
[TBL] [Abstract][Full Text] [Related]
9. On-line monitoring of breath by membrane extraction with sorbent interface coupled with CO2 sensor.
Yu Y; Pawliszyn J
J Chromatogr A; 2004 Nov; 1056(1-2):35-41. PubMed ID: 15595530
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of breath analysis--focus on volatile organic compounds.
Miekisch W; Schubert JK; Noeldge-Schomburg GF
Clin Chim Acta; 2004 Sep; 347(1-2):25-39. PubMed ID: 15313139
[TBL] [Abstract][Full Text] [Related]
11. Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.
Probert CS; Ahmed I; Khalid T; Johnson E; Smith S; Ratcliffe N
J Gastrointestin Liver Dis; 2009 Sep; 18(3):337-43. PubMed ID: 19795029
[TBL] [Abstract][Full Text] [Related]
12. Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes.
Storer M; Dummer J; Lunt H; Scotter J; McCartin F; Cook J; Swanney M; Kendall D; Logan F; Epton M
J Breath Res; 2011 Dec; 5(4):046011. PubMed ID: 22134047
[TBL] [Abstract][Full Text] [Related]
13. GC-MS analysis of breath odor compounds in liver patients.
Van den Velde S; Nevens F; Van Hee P; van Steenberghe D; Quirynen M
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):344-8. PubMed ID: 18938115
[TBL] [Abstract][Full Text] [Related]
14. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
15. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
16. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
17. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus?
Smith D; Spaněl P; Fryer AA; Hanna F; Ferns GA
J Breath Res; 2011 Jun; 5(2):022001. PubMed ID: 21512208
[TBL] [Abstract][Full Text] [Related]
18. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
[TBL] [Abstract][Full Text] [Related]
19. Potential of breath and skin analysis for monitoring blood glucose concentration in diabetes.
Turner C
Expert Rev Mol Diagn; 2011 Jun; 11(5):497-503. PubMed ID: 21707458
[TBL] [Abstract][Full Text] [Related]
20. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry.
O'Hara ME; O'Hehir S; Green S; Mayhew CA
Physiol Meas; 2008 Mar; 29(3):309-30. PubMed ID: 18367807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
